EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Cyto toxic and blocking antibodies in the serum and in eluates from the splenic cells of mice with different courses of rauscher leukemia



Cyto toxic and blocking antibodies in the serum and in eluates from the splenic cells of mice with different courses of rauscher leukemia



Byulleten' Eksperimental'noi Biologii i Meditsiny 79(2): 76-80




(PDF emailed within 1 workday: $29.90)

Accession: 026358682

Download citation: RISBibTeXText



Related references

Cyto toxic and blocking antibodies in serum and spleen cell eluates of mice with rauscher leukemia depending on its course. Bulletin Of Experimental Biology & Medicine: 174-177, 1975

Cytotoxic and blocking antibodies in the sera and eluates from spleen cells of mice with Rauscher leukemia following a different course. Biulleten' Eksperimental'noi Biologii i Meditsiny 79(2): 76-80, 1975

Blocking activity in vitro and biological effect of IgG (7S-antibodies) isolated from the spleen cells and serum of mice with progressive Rauscher leukemia. Biulleten' Eksperimental'noi Biologii i Meditsiny 78(12): 55-58, 1974

In vitro blocking activity and the biological effect of immuno globulin g 7s antibodies isolated from spleen cells and serum of mice with progressive rauscher leukemia. Byulleten' Eksperimental'noi Biologii i Meditsiny 78(12): 55-58, 1974

Distribution of cyto toxic antibodies and antibodies blocking the cyto toxic reaction depending on levels of classes of immuno globulins in children with acute leukemia. Pediatriya (Moscow) 8: 12-15, 1974

Rauscher leukemia as a model for cancer therapy studies 2. variation in response of splenic pluripotential stem cells between normal and rauscher leukemic mice following exposure to hydroxy urea. Proceedings of the Society for Experimental Biology and Medicine 163(1): 132-136, 1980

Cyto toxic effect of lymphocytes from pregnant mice on cultivated tumor cells part 1 specificity nature of effector cells and blocking by serum. International Journal of Cancer 15(1): 1-16, 1975

Mechanisms involved in the maintenance of the neo natally induced transplantation tolerance in mice 1 areactivity of precursors to cyto toxic t cells and cyto toxic t cells to the tolerated cells in vivo is not mediated by serum factors. 1979

Cyto toxic antibodies in the serum of c 3h mice inoculated with spontaneous mammary tumor cells. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii (9): 57-61, 1979

Cyto toxic effect of lymphocytes from pregnant mice on cultivated tumor cells part 2 blocking and unblocking of cyto toxicity. International Journal of Cancer 15(1): 30-38, 1975

Rauscher leukemia as a model for cancer therapy studies. II. Variation in response of splenic CFU-S between normal and Rauscher leukemic mice following exposure to hydroxyurea. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 163(1): 132-136, 1980

Polyadenylated RNA and poly-A segments in the splenic cells of mice with virus-induced Rauscher leukemia. Voprosy Meditsinskoi Khimii 29(6): 63-69, 1983

Mouse allo antibodies capable of blocking cyto toxic thymus derived cell function 2. further study on the relationship between the blocking antibodies and the products of the lyt 2 locus. European Journal of Immunology 10(8): 589-594, 1980

Mouse allo antibodies capable of blocking cyto toxic thymus derived cell function 1. relationship between the antigen reactive with blocking antibodies and the lyt 2 locus. Journal of Experimental Medicine 150(3): 432-444, 1979

Mouse allo antibodies capable of blocking cyto toxic t cell function 3. studies of the mechanism of blocking of cell mediated lympholysis by anti lyt 2 antibodies. Journal of Immunology 127(4): 1575-1578, 1981